Fluidigm Corp. (NASDAQ:FLDM)‘s stock had its “buy” rating restated by equities researchers at Cantor Fitzgerald in a note issued to investors on Saturday. They presently have a $9.00 target price on the stock, down from their previous target price of $11.00. Cantor Fitzgerald’s target price points to a potential upside of 101.34% from the company’s current price.

Several other research firms have also commented on FLDM. Mizuho raised their price target on shares of Fluidigm Corp. from $11.00 to $12.00 and gave the company a “buy” rating in a report on Friday, August 5th. Zacks Investment Research lowered shares of Fluidigm Corp. from a “buy” rating to a “hold” rating in a research note on Monday, July 11th. Three research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus target price of $13.48.

Analyst Recommendations for Fluidigm Corp. (NASDAQ:FLDM)

Shares of Fluidigm Corp. (NASDAQ:FLDM) opened at 4.47 on Friday. Fluidigm Corp. has a 52-week low of $4.41 and a 52-week high of $12.09. The stock’s market cap is $129.79 million. The company has a 50-day moving average of $8.12 and a 200 day moving average of $9.11.

Fluidigm Corp. (NASDAQ:FLDM) last posted its quarterly earnings results on Thursday, August 4th. The company reported ($0.64) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.58) by $0.06. Fluidigm Corp. had a negative net margin of 52.04% and a negative return on equity of 45.68%. The business earned $28.20 million during the quarter, compared to analysts’ expectations of $29.62 million. During the same quarter in the previous year, the business posted ($0.53) EPS. The company’s quarterly revenue was down 1.5% on a year-over-year basis. Equities research analysts forecast that Fluidigm Corp. will post ($2.32) EPS for the current fiscal year.

Several hedge funds have recently added to or reduced their stakes in the company. Cookson Peirce & Co. Inc. bought a new stake in Fluidigm Corp. during the second quarter worth $123,000. BlackRock Advisors LLC increased its stake in Fluidigm Corp. by 10.4% in the second quarter. BlackRock Advisors LLC now owns 14,529 shares of the company’s stock worth $131,000 after buying an additional 1,373 shares during the last quarter. Parametric Portfolio Associates LLC increased its stake in Fluidigm Corp. by 89.3% in the second quarter. Parametric Portfolio Associates LLC now owns 21,070 shares of the company’s stock worth $190,000 after buying an additional 9,939 shares during the last quarter. Stoneridge Investment Partners LLC bought a new stake in Fluidigm Corp. during the second quarter worth $220,000. Finally, AQR Capital Management LLC increased its stake in Fluidigm Corp. by 58.8% in the second quarter. AQR Capital Management LLC now owns 25,187 shares of the company’s stock worth $227,000 after buying an additional 9,324 shares during the last quarter. 93.33% of the stock is owned by institutional investors and hedge funds.

Fluidigm Corp. Company Profile

Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company’s core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment.

5 Day Chart for NASDAQ:FLDM

Receive News & Stock Ratings for Fluidigm Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fluidigm Corp. and related stocks with our FREE daily email newsletter.